PetMed Express, Inc. (PETS) Revenue History
Annual and quarterly revenue from 2000 to present
PETS Revenue Over Time (2000–2026)
PETS Revenue Growth History
18 of 26 years with positive growth- FY2000 revenue growth
- N/A
- FY2001 revenue growth
- -31.8%
- FY2002 revenue growth
- +220.1%
- FY2003 revenue growth
- +71.7%
- FY2004 revenue growth
- +71.0%
- FY2005 revenue growth
- +15.3%
- FY2006 revenue growth
- +27.0%
- FY2007 revenue growth
- +17.9%
- FY2008 revenue growth
- +16.1%
- FY2009 revenue growth
- +16.5%
- FY2010 revenue growth
- +8.6%
- FY2011 revenue growth
- -2.8%
- FY2012 revenue growth
- +2.9%
- FY2013 revenue growth
- -4.4%
- FY2014 revenue growth
- +2.4%
- FY2015 revenue growth
- -1.7%
- FY2016 revenue growth
- +2.3%
- FY2017 revenue growth
- +6.2%
- FY2018 revenue growth
- +9.9%
- FY2019 revenue growth
- +3.5%
- FY2020 revenue growth
- +0.2%
- FY2021 revenue growth
- +6.8%
- FY2022 revenue growth
- -9.9%
- FY2023 revenue growth
- -6.2%
- FY2024 revenue growth
- +6.8%
- FY2025 revenue growth
- -17.2%
- FY2026 revenue growth
- -21.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2026 | $42.8M | -7.9% |
| Q3 2026 | $40.7M | -23.3% |
| Q2 2026 | $44.4M | -25.5% |
| Q1 2026 | $51.2M | -24.7% |
| Q4 2025 | $46.5M | -30.1% |
| Q3 2025 | $53.0M | -18.9% |
| Q2 2025 | $59.6M | -16.1% |
| Q1 2025 | $68.0M | -13.2% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2026)
PETS's revenue distribution by segment and geography for fiscal year 2026
By Product/Segment
PETS Revenue Analysis (2000–2026)
Current Revenue & Growth
As of June 22, 2026, PetMed Express, Inc. (PETS) generated trailing twelve-month (TTM) revenue of $179.0 million, reflecting moderate decline in growth of -7.9% year-over-year. The most recent quarter (Q4 2026) recorded $42.8 million in revenue, up 5.3% sequentially.
Historical Growth Trajectory
PETS's 5-year compound annual growth rate (CAGR) stands at -10.0%, indicating revenue contraction over this period. The 3-year CAGR of -11.3% is below the 5-year average, signalling a growth deceleration in recent years. PetMed Express, Inc.'s highest annual revenue of $303.6 million was recorded in 2021.
Revenue by Segment
PETS's revenue is primarily driven by Membership (100%). With over half of revenue concentrated in Membership, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including CHWY (+2.1% YoY), WOOF (-1.2% YoY), and FRPT (+12.0% YoY) — PETS has underperformed the peer group in revenue growth. Compare PETS vs CHWY →
PETS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PETSCurrent | $179M | -7.9% | -10.0% | -17.5% | |
 CHWY | $12.6B | +2.1% | +12.0% | 2.0% | |
 WOOF | $6.0B | -1.2% | +3.9% | 2.0% | |
 FRPT | $1.1B | +12.0% | +28.2% | 8.6% | |
 HIMS | $2.3B | +32.8% | +73.6% | 4.5% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% |
PETS Historical Revenue Data (2000–2026)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $179.0M | -21.1% | $50.2M | 28.1% | $-31,415,000 | -17.5% |
| 2025 | $227.0M | -17.2% | $69.1M | 30.5% | $-1,530,000 | -0.7% |
| 2024 | $274.1M | +6.8% | $77.7M | 28.4% | $-6,962,000 | -2.5% |
| 2023 | $256.6M | -6.2% | $71.0M | 27.7% | $6.6M | 2.6% |
| 2022 | $273.4M | -9.9% | $75.3M | 27.6% | $25.7M | 9.4% |
| 2021 | $303.6M | +6.8% | $84.3M | 27.8% | $30.5M | 10.1% |
| 2020 | $284.1M | +0.2% | $81.2M | 28.6% | $31.0M | 10.9% |
| 2019 | $283.4M | +3.5% | $95.3M | 33.6% | $46.2M | 16.3% |
| 2018 | $273.8M | +9.9% | $97.8M | 35.7% | $52.1M | 19.0% |
| 2017 | $249.2M | +6.2% | $79.3M | 31.8% | $37.5M | 15.0% |
| 2016 | $234.7M | +2.3% | $76.3M | 32.5% | $32.4M | 13.8% |
| 2015 | $229.4M | -1.7% | $76.3M | 33.2% | $27.6M | 12.0% |
| 2014 | $233.4M | +2.4% | $77.6M | 33.3% | $28.2M | 12.1% |
| 2013 | $227.8M | -4.4% | $77.1M | 33.9% | $27.0M | 11.9% |
| 2012 | $238.3M | +2.9% | $80.2M | 33.6% | $26.0M | 10.9% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PETS — Frequently Asked Questions
Quick answers to the most common questions about buying PETS stock.
Is PETS's revenue growth accelerating or slowing?
PETS revenue is declining -7.9% year-over-year. TTM revenue fell to $179M, contrasting with the 5-year CAGR of -10.0%. The reversal reflects either macro headwinds or company-specific challenges.
What is PETS's revenue history from 2000 to 2026?
PetMed Express, Inc. (PETS) revenue history spans 2000 to 2026. TTM revenue as of 2026 is $179M, growing at -7.9% YoY. The 5-year CAGR is -10.0%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is PETS's long-term revenue growth rate (CAGR)?
PetMed Express, Inc.'s 5-year revenue CAGR of -10.0% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -7.9% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PETS.
Why does PETS's quarterly revenue fluctuate?
PETS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. PetMed Express, Inc.'s revenue data from 2000 to 2026 shows full historical quarterly detail on this page.
How is PETS's revenue distributed by segment?
PETS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does PETS's revenue compare to industry peers?
PetMed Express, Inc. (PETS) with TTM revenue of $179M and -7.9% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.